Nepal vs Sri Lanka: New cases tested for RR-/MDR-TB
Nepal
70.0%
in 2024
Sri Lanka
69.0%
in 2024
Nepal rank
141st
Sri Lanka rank
144th
New cases tested for RR-/MDR-TB over time
- Nepal
- Sri Lanka
How they compare
Nepal currently reports 70.0% against 69.0% in Sri Lanka, a difference of 1.0%.
The two have swapped places 3 times across 17 shared years of data; in 2007 it was Sri Lanka ahead.
Nepal ranks 141st and Sri Lanka ranks 144th of 192 countries.
Across the 3 decades both report, Nepal averaged higher in 2 and Sri Lanka in 1.
Head to head by decade
| Decade | Nepal | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.3% | 17.0% | 14.7% | Sri Lanka |
| 2010s | 31.2% | 29.7% | 1.5% | Nepal |
| 2020s | 77.8% | 48.2% | 29.5% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Nepal or Sri Lanka?
- Nepal, at 70.0% against 69.0% in Sri Lanka as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Nepal and Sri Lanka?
- 1.0%, with Nepal ahead.
- How many years of comparable data are there for Nepal and Sri Lanka?
- 17 years are reported by both, from 2007 to 2024.
- How do Nepal and Sri Lanka rank globally for new cases tested for rr-/mdr-tb?
- Nepal ranks 141st and Sri Lanka ranks 144th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.